recainam has been researched along with Arrhythmia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, JL; de Vane, PJ; Myerburg, RJ; Reddy, CP; Waxman, HL | 1 |
Capuzzi, DM; Feld, GK; Frame, VB; Greenspon, AJ; Horowitz, LN; Luceri, RM; Myerburg, RJ; Singh, BN | 1 |
Capuzzi, DM; Davies, RF; Echt, DS; Funck-Brentano, C; Lee, JT; Lineberry, MD; Roden, DM; Woosley, RL | 1 |
Anastasiou-Nana, MI; Anderson, JL; Hampton, EM; Heath, BM; Nanas, JN | 1 |
3 trial(s) available for recainam and Arrhythmia
Article | Year |
---|---|
Antiarrhythmic and pharmacokinetic evaluation of intravenous recainam in patients with frequent ventricular premature complexes and unsustained ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phenylurea Compounds; Tachycardia, Ventricular | 1993 |
Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phenylurea Compounds | 1991 |
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Tolerance; Electrocardiography; Humans; Infusions, Intravenous; Middle Aged; Phenylurea Compounds; Random Allocation | 1989 |
1 other study(ies) available for recainam and Arrhythmia
Article | Year |
---|---|
Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Phenylurea Compounds; Time Factors | 1986 |